 Coherus BioSciences, Inc. NASDAQ:CHRS Q2 2022 Earnings Conference Call August 4, 2022 5:00 PM ET Company Participants Marek Ciszewski Investor Relations Denny Lanfear Chief Executive Officer Rosh Dias Chief Medical Officer Paul Reider Chief Commercial Officer McDavid Stilwell Chief Financial Officer Conference Call Participants Ken Cacciatore Cowen and Company Douglas Tsao H.C. Wainwright Company Jason Gerberry Bank of America Ash Verma UBS Operator Ladies and gentlemen, thank you for standing by, and welcome to the Q2 2022 Coherus BioSciences, Inc. Earnings Conference Call. 